Ferdinand Althammer is a postdoctoral researcher in Christian Schaaf’s lab at the University of Heidelburg in Germany.
![Headshot of Ferdinand Althammer](https://www.thetransmitter.org/wp-content/uploads/2022/09/Ferdinand-Althammer-Cropped.jpg)
Ferdinand Althammer
Postdoctoral researcher
University of Heidelberg
From this contributor
Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer
Oxytocin therapies have failed to consistently benefit autistic people, but their effects in people with two autism-linked conditions may yield new insights, experts argue.
![](https://www.thetransmitter.org/wp-content/uploads/2022/09/Oxytocin-Prader-Willi-autism-therapy-844.jpg)
Oxytocin lessons from autism-linked syndromes: A chat with Christian Schaaf and Ferdinand Althammer
Explore more from The Transmitter
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
![](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200_coughingmice-1024x720.webp)
Cell population in brainstem coordinates cough, new study shows
The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
![Capitol building](https://www.thetransmitter.org/wp-content/uploads/2024/09/capitolhill-1200-1024x692.webp)
In updated U.S. autism bill, Congress calls for funding boost, expanded scope
The current Autism CARES Act sunsets in late September.
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.
![Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.](https://www.thetransmitter.org/wp-content/uploads/2024/09/1200-ketamine-receptor-transmitter-neuroscience-1024x683.webp)
Ketamine targets lateral habenula, setting off cascade of antidepressant effects
The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.